ATE201677T1 - 4-imidomethyl-1-(2'-phenyl-2-oxoethyl)-piperidi e als serotonin-5ht2-antagonisten, ihre herstellung und therapeutische anwendung - Google Patents
4-imidomethyl-1-(2'-phenyl-2-oxoethyl)-piperidi e als serotonin-5ht2-antagonisten, ihre herstellung und therapeutische anwendungInfo
- Publication number
- ATE201677T1 ATE201677T1 AT93908559T AT93908559T ATE201677T1 AT E201677 T1 ATE201677 T1 AT E201677T1 AT 93908559 T AT93908559 T AT 93908559T AT 93908559 T AT93908559 T AT 93908559T AT E201677 T1 ATE201677 T1 AT E201677T1
- Authority
- AT
- Austria
- Prior art keywords
- serotonin
- antagonists
- imidomethyl
- piperidi
- oxoethyl
- Prior art date
Links
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 title abstract 3
- 239000003215 serotonin 5-HT2 receptor antagonist Substances 0.000 title abstract 2
- 229940076279 serotonin Drugs 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87256692A | 1992-04-23 | 1992-04-23 | |
| US2250293A | 1993-03-10 | 1993-03-10 | |
| PCT/US1993/002771 WO1993022309A1 (en) | 1992-04-23 | 1993-03-24 | 4-imidomethyl-1-[2'phenyl-2'oxoethyl-] piperidines as serotonin 5ht2-antagonists, their preparation and use in therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE201677T1 true ATE201677T1 (de) | 2001-06-15 |
Family
ID=26695998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93908559T ATE201677T1 (de) | 1992-04-23 | 1993-03-24 | 4-imidomethyl-1-(2'-phenyl-2-oxoethyl)-piperidi e als serotonin-5ht2-antagonisten, ihre herstellung und therapeutische anwendung |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20020002174A1 (de) |
| EP (1) | EP0637306B1 (de) |
| JP (1) | JP3333878B2 (de) |
| KR (1) | KR100259107B1 (de) |
| AT (1) | ATE201677T1 (de) |
| AU (1) | AU671274B2 (de) |
| CA (1) | CA2134077C (de) |
| DE (1) | DE69330272T2 (de) |
| DK (1) | DK0637306T3 (de) |
| ES (1) | ES2158861T3 (de) |
| GR (1) | GR3036458T3 (de) |
| MX (1) | MX9302378A (de) |
| NZ (1) | NZ251610A (de) |
| PT (1) | PT637306E (de) |
| WO (1) | WO1993022309A1 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997030038A1 (en) * | 1996-02-15 | 1997-08-21 | Mitsubishi Chemical Corporation | Diarylsultam derivatives |
| GB0004549D0 (en) | 2000-02-25 | 2000-04-19 | Isis Innovation | Degradation fragments |
| NZ546991A (en) | 2003-11-20 | 2010-01-29 | Janssen Pharmaceutica Nv | 6-Alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as PARP inhibitors |
| NZ546990A (en) | 2003-11-20 | 2010-03-26 | Janssen Pharmaceutica Nv | 7-Phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| JP4806353B2 (ja) * | 2003-12-05 | 2011-11-02 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ポリ（ａｄｐ−リボース）ポリメラーゼインヒビターとしての６−置換２−キノリノンおよび２−キノキサリノン |
| JP5100376B2 (ja) * | 2004-06-30 | 2012-12-19 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Ｐａｒｐ阻害剤としてのキナゾリンジオン誘導体 |
| WO2006003147A1 (en) | 2004-06-30 | 2006-01-12 | Janssen Pharmaceutica N.V. | Phthalazine derivatives as parp inhibitors |
| CA2568835C (en) | 2004-06-30 | 2014-05-27 | Janssen Pharmaceutica N.V. | Quinazolinone derivatives as parp inhibitors |
| JP5545955B2 (ja) | 2007-03-08 | 2014-07-09 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Ｐａｒｐおよびｔａｎｋ阻害剤としてのキノリノン誘導体 |
| WO2009053373A1 (en) | 2007-10-26 | 2009-04-30 | Janssen Pharmaceutica Nv | Quinolinone derivatives as parp inhibitors |
| DK2271626T3 (en) | 2008-03-27 | 2015-02-23 | Janssen Pharmaceutica Nv | TETRAHYDROPHENANTHRIDINONES AND TETRAHYDROCYCLOPENTAQUINOLINONES AS INHIBITORS OF POLYMERIZATION OF PARP AND TUBULIN |
| WO2009118384A1 (en) | 2008-03-27 | 2009-10-01 | Janssen Pharmaceutica Nv | Quinazolinone derivatives as tubulin polymerization inhibitors |
| RU2746871C2 (ru) * | 2010-07-20 | 2021-04-21 | Сиренейк Фармасьютикалз Инк. | Способы применения производных циклического амида для лечения опосредуемых сигма-рецепторами расстройств |
| US10179776B2 (en) | 2014-06-09 | 2019-01-15 | Intra-Cellular Therapies, Inc. | Compounds and methods of use to treat schizophrenia |
| JP2020525436A (ja) | 2017-06-21 | 2020-08-27 | ミネルバ・ニューロサイエンシズ・インコーポレイテッド | 胃耐性制御放出経口剤形 |
| CN117820199A (zh) * | 2022-09-28 | 2024-04-05 | 瀚远医药有限公司 | 一种酰胺类化合物及其制备Sigma2和5HT2A抑制剂的用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU593194B2 (en) * | 1986-09-26 | 1990-02-01 | Sumitomo Pharmaceuticals Company, Limited | Imide derivatives ,and their production and use |
| FR2643373B1 (fr) * | 1989-01-10 | 1993-12-31 | Adir Cie | Nouveaux derives des bisarylalcenes, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
| GB8906166D0 (en) * | 1989-03-17 | 1989-05-04 | Pfizer Ltd | Therapeutic agents |
| EP0497843A4 (en) * | 1989-10-27 | 1992-09-23 | The Du Pont Merck Pharmaceutical Company | (n-phthalimidoalkyl) piperidines |
| JP2807577B2 (ja) * | 1990-06-15 | 1998-10-08 | エーザイ株式会社 | 環状アミド誘導体 |
| US5098904A (en) * | 1990-06-27 | 1992-03-24 | Bristol-Myers Squibb Company | Cerebral function enhancing pyrimidinyl derivatives |
| US5231099A (en) * | 1991-04-15 | 1993-07-27 | Du Pont Merck Pharmaceutical Company | Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs |
| ES2164639T3 (es) * | 1991-04-15 | 2002-03-01 | Aventis Pharma Gmbh | Quinoxalinas, procedimiento para su preparacion y su empleo. |
-
1993
- 1993-03-24 JP JP51925593A patent/JP3333878B2/ja not_active Expired - Fee Related
- 1993-03-24 ES ES93908559T patent/ES2158861T3/es not_active Expired - Lifetime
- 1993-03-24 NZ NZ251610A patent/NZ251610A/en unknown
- 1993-03-24 DK DK93908559T patent/DK0637306T3/da active
- 1993-03-24 KR KR1019940703742A patent/KR100259107B1/ko not_active Expired - Fee Related
- 1993-03-24 PT PT93908559T patent/PT637306E/pt unknown
- 1993-03-24 CA CA002134077A patent/CA2134077C/en not_active Expired - Fee Related
- 1993-03-24 EP EP93908559A patent/EP0637306B1/de not_active Expired - Lifetime
- 1993-03-24 WO PCT/US1993/002771 patent/WO1993022309A1/en not_active Ceased
- 1993-03-24 AU AU39341/93A patent/AU671274B2/en not_active Ceased
- 1993-03-24 AT AT93908559T patent/ATE201677T1/de not_active IP Right Cessation
- 1993-03-24 DE DE69330272T patent/DE69330272T2/de not_active Expired - Fee Related
- 1993-04-23 MX MX9302378A patent/MX9302378A/es unknown
-
2000
- 2000-05-19 US US09/575,023 patent/US20020002174A1/en not_active Abandoned
-
2001
- 2001-08-27 GR GR20010401308T patent/GR3036458T3/el not_active IP Right Cessation
-
2002
- 2002-06-21 US US10/177,996 patent/US20030083325A1/en not_active Abandoned
-
2003
- 2003-04-09 US US10/410,485 patent/US20030212141A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2158861T3 (es) | 2001-09-16 |
| NZ251610A (en) | 1996-02-27 |
| AU3934193A (en) | 1993-11-29 |
| DE69330272T2 (de) | 2001-10-25 |
| KR100259107B1 (ko) | 2000-07-01 |
| EP0637306B1 (de) | 2001-05-30 |
| US20030212141A1 (en) | 2003-11-13 |
| KR950701332A (ko) | 1995-03-23 |
| CA2134077C (en) | 2002-05-21 |
| JPH07506107A (ja) | 1995-07-06 |
| DK0637306T3 (da) | 2001-07-30 |
| MX9302378A (es) | 1994-05-31 |
| GR3036458T3 (en) | 2001-11-30 |
| US20020002174A1 (en) | 2002-01-03 |
| DE69330272D1 (de) | 2001-07-05 |
| PT637306E (pt) | 2001-10-30 |
| JP3333878B2 (ja) | 2002-10-15 |
| EP0637306A1 (de) | 1995-02-08 |
| US20030083325A1 (en) | 2003-05-01 |
| WO1993022309A1 (en) | 1993-11-11 |
| CA2134077A1 (en) | 1993-11-11 |
| AU671274B2 (en) | 1996-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69330272D1 (de) | 4-imidomethyl-1-[2'-phenyl-2-oxoethyl]-piperidine als serotonin-5ht2-antagonisten, ihre herstellung und therapeutische anwendung | |
| NO924619D0 (no) | (+)-alfa-(2,3-dimetoksyfenyl)-1-(2-(4-fluorfenyl)ethyl)-4-piperidinmetanol | |
| FI933946A7 (fi) | Hypoglykeemisinä aineina ja Alzheimerin taudin hoidossa käyttökelpoisia yhdisteitä | |
| ATE150015T1 (de) | Substituierte tetrahydroisochinolin-derivate und ihre anwendung in der therapie | |
| DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| SE9604786D0 (sv) | New compounds | |
| DE69721766D1 (de) | Neue arzneiformulierung | |
| AU8676091A (en) | 3-amidoindolyl derivatives | |
| CA2129995A1 (en) | Piperidinyl thiacyclic derivatives | |
| ATE188965T1 (de) | Neue pyrazincarboxamidderivate, ihre herstellung und ihre verwendung in arzneimitteln | |
| ATE208620T1 (de) | Kombinationspräparat zur anwendung bei immunologischen erkrankungen | |
| SE9502893D0 (sv) | Användning av kollagenas | |
| DE69420251D1 (de) | Löslicher Interferon-Rezeptor, seine Herstellung und Anwendung | |
| DE3875866D1 (de) | Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie. | |
| EE200200337A (et) | Uued ühendid ning nende kasutamine | |
| DE69808921D1 (de) | 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOL-1-ACETAMID-DERIVATE, IHRE HERSTELLUNG UND THERAPEUTISCHE ANWENDUNG | |
| LV11940A (lv) | Melatonina pielietojums personu arstesanai kuras cies no zalu atkaribas | |
| DE69120933D1 (de) | Topische Anwendung von Glycosaminoglykane zur Prävention und Behandlung der Zervikal- oder Vaginalerkrankungen | |
| MD1140B1 (en) | Remedy possessing a regenerative and cytoprotective activity | |
| ATE205841T1 (de) | Derivate von 5-naphthalin-1-yl-1,3-dioxanen, ihre herstellung und therapeutische anwendung | |
| DE69424415D1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
| RU94024337A (ru) | Антиметастатическое средство | |
| ATE230608T1 (de) | Verwendung von bradykinin-antagonisten zur herstellung von arzneimitteln zur behandlung und prävention der alzheimer'schen krankheit | |
| RU92007680A (ru) | Средство, обладающее тонизирующим действием на гладкую мускулатуру вен, мочевого пузыря и предстательной железы | |
| ATE221528T1 (de) | Neue 1,4-dihydropyridinderivate und deren therapeutische anwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |